Data / Form D filings / Illuminare Biotechnologies Inc
Illuminare Biotechnologies Inc: Form D filings
Illuminare Biotechnologies Inc, a biotechnology company in Brooklyn, NY, filed 3 Form D notices with the SEC between 2017 and 2026. The latest, on June 4, 2026, reports $3.7 million sold of a $4 million offering to 42 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 327 St Marks Avenue, Brooklyn, NY, 11238
- Phone
- (609) 497-1282
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1701523
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | New notice | $4,000,000 | $3,650,000 | $350,000 | 42 | May 7, 2026 | sec.gov |
| Dec 17, 2018 | New notice | $2,500,000 | $0 | $2,500,000 | 0 | Dec 17, 2018 | sec.gov |
| Aug 18, 2017 | New notice | $2,500,000 | $2,373,677 | $126,323 | 44 | Aug 14, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Graifman | Director, Promoter | |
| Oliver Curme | Director | |
| Shay Grinfeld | Director, Promoter | |
| Walter Greenblatt | Executive Officer, Director, Promoter | |
| Eric Edidin | Director | |
| Brian Longstreet | Executive Officer, Director | |
| Andrew Fradkin | Promoter | |
| Ezra Angrist | Promoter |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Jun 1, 2026 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Illuminare Biotechnologies Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.